SCHEMBL13115661

SCHEMBL13115661

CCOC(=O)Cc1nc(-c2cc3ccccc3s2)oc1-c1ccc(Cl)s1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 1/20 0.42
L3MBTL1 Q9Y468 3/20 0.41
NPSR1 Q6W5P4 2/20 0.41
PPARG P37231 1/20 0.39
PPARA Q07869 1/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
JAK2 O60674 1/20 0.38
JAK3 P52333 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
PKM P14618 1/20 0.37
NFKB1 P19838 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
ALDH1A1 P00352 4/20 0.37
MAPT P10636 3/20 0.37
TNIK Q9UKE5 1/20 0.36
KDM4E B2RXH2 4/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13116077 0.89 MEN1 (0.39) L3MBTL1NPSR1MEN1KMT2ASMN1; SMN2
SCHEMBL13116078 0.88 NPSR1 (0.39) L3MBTL1NPSR1MEN1KMT2ASMN1; SMN2
SCHEMBL13116255 0.87 HSD17B10 (0.45) IKBKBL3MBTL1PPARGPPARAMEN1
SCHEMBL13116036 0.87 L3MBTL1 (0.37) L3MBTL1NPSR1PPARGMEN1KMT2A
SCHEMBL13115641 0.86 IKBKB (0.42) IKBKBL3MBTL1NPSR1PPARGPPARA
SCHEMBL2818310 0.86 IKBKB (0.46) IKBKBNPSR1PPARGPPARAMEN1
SCHEMBL13116195 0.85 IKBKB (0.41) IKBKBL3MBTL1NPSR1PPARGPPARA
SCHEMBL13116039 0.85 MEN1 (0.41) L3MBTL1NPSR1MEN1KMT2ASMN1; SMN2
SCHEMBL13115656 0.85 SMN1; SMN2 (0.50) L3MBTL1PPARGMEN1KMT2ASMN1; SMN2
SCHEMBL13116048 0.84 MEN1 (0.43) L3MBTL1NPSR1PPARGMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100256165-A1 LARGE CONDUCTANCE CALCIUM-ACTIVATED K CHANNEL OPENER HONGU MITSUYA 2010-10-07 US disclosed
US-20100256165-A1 LARGE CONDUCTANCE CALCIUM-ACTIVATED K CHANNEL OPENER HONGU MITSUYA 2010-10-07 US disclosed
US-7759373-B2 Large conductance calcium-activated K channel opener MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-07-20 US disclosed
US-7759373-B2 Large conductance calcium-activated K channel opener MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256165-A1 LARGE CONDUCTANCE CALCIUM-ACTIVATED K CHANNEL OPENER KCNN3, KCNN2, KCNN1 IKBKB 1109/4885L3MBTL1 3792/4885NPSR1 822/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.